【药物名称】Teglicar, ST-1326
化学结构式(Chemical Structure):
参考文献No.41262
标题:Cpds. having reversible inhibiting activity of carnitine palmitoyl-transferase
作者:Marzi, M.; Tinti, M.O.; Giannessi, F.; Minetti, P.; De Angelis, F.; Chiodi, P.; Arduini, A. (Sigma-Tau Industrie Farmaceutiche Riunite SpA)
来源:EP 1077925; US 6369073; WO 9959957
合成路线图解说明:

Pentadecanoyl chloride (I) is treated with NaN3 to form the corresponding acyl azide (II), which undergoes Curtius rearrangement to isocyanate (III) upon heating in toluene. Coupling of isocyanate (III) with aminocarnitine (IV) then produces the title urea derivative.

合成路线图解说明:

(R)-Aminocarnitine (I) was esterified with HCl in refluxing isobutanol to afford the isobutyl ester (II). Acylation of amino ester (II) with dodecanesulfonyl chloride (III) in the presence of triethylamine provided the corresponding sulfonamide (IV). The title compound was then obtained by basic hydrolysis of the isobutyl ester group of (IV).

参考文献No.592801
标题:Reversible carnitine palmitoyltransferase inhibitors with antidiabetic activity. 2. Aminocarnitine derivatives
作者:Catii, R.; Arduini, A.; Calvisi, G.; et al.
来源:16th Int Symp Med Chem (Sept 18 2000, Bologna) 2000,Abst PC-13
合成路线图解说明:

Pentadecanoyl chloride (I) is treated with NaN3 to form the corresponding acyl azide (II), which undergoes Curtius rearrangement to isocyanate (III) upon heating in toluene. Coupling of isocyanate (III) with aminocarnitine (IV) then produces the title urea derivative.

Drug Information Express,Drug R&D,Chemical Database,Patent Search.
Copyright © 2006-2024 Drug Future. All rights reserved.Contact Us